Real-World Outcomes of Women With HER2-Positive Early Breast Cancer Receiving Adjuvant Trastuzumab
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Real world evidence of adjuvant trastuzumab in HER2 positive early breast cancer
Sci Rep 2023 May 03;13(1)7168, J Lluch-Gómez, V Núñez-Álvarez, C de la Torre-Hita, M Bernal-Gómez, A Campini-Bermejo, E Perdomo-Zaldívar, L Rodríguez-Pérez, J Calvete-Candenas, MJ Martínez-Bautista, E Benítez-Rodríguez, JM Baena-CañadaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.